Vitamin B6 (Pyridoxine) Deficiency
Overview
Plain-Language Overview
Vitamin B6 (Pyridoxine) Deficiency occurs when the body lacks enough of this important vitamin, which plays a key role in many bodily functions. It mainly affects the nervous system and the production of red blood cells. People with this deficiency may experience symptoms like irritability, depression, and peripheral neuropathy, which means numbness or tingling in the hands and feet. The deficiency can also cause problems with the skin, such as a rash or cracks around the mouth. Since Vitamin B6 helps the body process proteins and make neurotransmitters, its lack can disrupt many normal processes.
Clinical Definition
Vitamin B6 (Pyridoxine) Deficiency is a condition characterized by insufficient levels of pyridoxine, a water-soluble vitamin essential for amino acid metabolism, neurotransmitter synthesis, and hemoglobin production. The deficiency results from inadequate dietary intake, malabsorption, increased requirements (e.g., pregnancy), or drug interactions (e.g., isoniazid, hydralazine). It leads to impaired function of pyridoxal phosphate-dependent enzymes, causing neurological symptoms such as peripheral neuropathy, seizures, and cheilitis, as well as hematologic abnormalities like microcytic anemia. The deficiency disrupts neurotransmitter synthesis including GABA, dopamine, and serotonin, contributing to neuropsychiatric manifestations. Early recognition is critical due to the potential reversibility of symptoms with supplementation.
Inciting Event
Initiation of isoniazid therapy without pyridoxine supplementation.
Development of malabsorption due to gastrointestinal diseases.
Excessive alcohol consumption leading to nutritional deficiency.
Increased metabolic demand during pregnancy or lactation.
Chronic renal failure causing increased vitamin B6 loss.
Latency Period
Symptoms typically develop over weeks to months of inadequate vitamin B6 intake or increased requirement.
Neurological manifestations may appear within 1 to 3 months after starting isoniazid without supplementation.
In malabsorption, symptom onset varies depending on severity but often occurs within several months.
In chronic alcoholism, deficiency develops insidiously over months to years.
Pregnancy-related deficiency symptoms may arise in the second or third trimester.
Diagnostic Delay
Neurological symptoms are often misattributed to alcohol-related neuropathy or other vitamin deficiencies.
Lack of routine measurement of plasma pyridoxal phosphate levels delays diagnosis.
Overlap with symptoms of other nutritional deficiencies such as vitamin B12 or folate.
Failure to recognize drug-induced pyridoxine deficiency in patients on isoniazid.
Non-specific symptoms like irritability and peripheral neuropathy lead to delayed consideration of vitamin B6 deficiency.
Clinical Presentation
Signs & Symptoms
Peripheral neuropathy with numbness, tingling, and burning sensations in hands and feet
Cheilitis and glossitis causing oral discomfort and difficulty eating
Irritability, depression, and confusion reflecting central nervous system involvement
Seizures in severe or prolonged deficiency due to impaired neurotransmitter metabolism
Microcytic anemia may occur due to impaired heme synthesis
History of Present Illness
Progressive peripheral neuropathy characterized by burning, numbness, and paresthesias in a stocking-glove distribution.
Development of seizures or convulsions refractory to standard anticonvulsants in severe deficiency.
Symptoms of cheilitis, glossitis, and stomatitis indicating mucosal involvement.
Irritability, depression, and confusion reflecting central nervous system dysfunction.
In infants, presentation includes irritability, seizures, and failure to thrive.
Past Medical History
History of tuberculosis treated with isoniazid without pyridoxine supplementation.
Chronic gastrointestinal disorders such as celiac disease or Crohn disease.
Long-standing alcohol use disorder with poor nutritional status.
Previous episodes of seizures or neuropathy unexplained by other causes.
Chronic renal insufficiency or dialysis treatment.
Family History
Rare familial cases of pyridoxine-dependent epilepsy due to mutations in the ALDH7A1 gene.
No common hereditary pattern for nutritional vitamin B6 deficiency.
Family history of inborn errors of metabolism affecting vitamin B6 utilization may be relevant.
No significant familial clustering in acquired deficiency states.
Genetic predisposition to malabsorption syndromes may indirectly increase risk.
Physical Exam Findings
Cheilitis characterized by painful, cracked lips and angular stomatitis
Glossitis presenting as a smooth, beefy red tongue due to mucosal atrophy
Peripheral neuropathy signs including decreased vibration and proprioception
Irritability and other neuropsychiatric symptoms such as confusion or depression
Seizures in severe cases due to impaired neurotransmitter synthesis
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by measuring low plasma or serum levels of pyridoxal 5'-phosphate (PLP), the active form of Vitamin B6. Clinical suspicion arises from characteristic symptoms such as peripheral neuropathy, seborrheic dermatitis, and microcytic anemia unresponsive to iron therapy. Additional supportive findings include elevated levels of homocysteine and xanthurenic acid in urine after tryptophan load. Confirmatory diagnosis is supported by clinical improvement following pyridoxine supplementation.
Pathophysiology
Key Mechanisms
Impaired activity of pyridoxal 5'-phosphate, the active form of vitamin B6, disrupts amino acid metabolism and neurotransmitter synthesis.
Deficiency leads to decreased synthesis of gamma-aminobutyric acid (GABA), causing neurological symptoms such as seizures.
Reduced function of enzymes dependent on vitamin B6, including transaminases and decarboxylases, impairs heme synthesis and neurotransmitter production.
Accumulation of homocysteine due to impaired conversion to cystathionine increases risk of vascular and neurological damage.
| Involvement | Details |
|---|---|
| Organs | Brain involvement manifests as seizures and irritability due to impaired neurotransmitter synthesis. |
Liver plays a role in vitamin B6 metabolism and storage, and dysfunction can exacerbate deficiency. | |
| Tissues | Peripheral nerves are damaged due to impaired neurotransmitter production causing neuropathy. |
Bone marrow tissue shows ineffective heme synthesis leading to sideroblastic anemia. | |
| Cells | Neurons are affected due to impaired neurotransmitter synthesis leading to peripheral neuropathy. |
Erythrocytes show abnormal hemoglobin synthesis contributing to microcytic anemia. | |
| Chemical Mediators | Pyridoxal phosphate is the active form of vitamin B6 and a coenzyme for enzymes involved in amino acid metabolism and neurotransmitter synthesis. |
Gamma-aminobutyric acid (GABA) synthesis is decreased due to vitamin B6 deficiency, contributing to neurological symptoms. |
Treatments
Pharmacological Treatments
Pyridoxine (Vitamin B6) supplementation
- Mechanism:
Repletes deficient pyridoxal phosphate, a coenzyme essential for amino acid metabolism and neurotransmitter synthesis.
- Side effects:
Sensory neuropathy with high doses
Photosensitivity
Gastrointestinal upset
- Clinical role:
First-line
Non-pharmacological Treatments
Dietary modification to increase intake of vitamin B6-rich foods such as poultry, fish, potatoes, and fortified cereals.
Avoidance of medications that interfere with vitamin B6 metabolism, such as isoniazid and hydralazine.
Management of underlying conditions causing malabsorption or increased vitamin B6 requirements.
Prevention
Pharmacological Prevention
Prophylactic pyridoxine supplementation in patients on isoniazid therapy
Vitamin B6 supplementation in chronic kidney disease to prevent deficiency
Supplementation during pregnancy to prevent deficiency-related complications
Use of multivitamins containing pyridoxine in malnourished or alcoholic patients
Administration of pyridoxine in genetic enzyme deficiencies affecting metabolism
Non-pharmacological Prevention
Dietary intake of vitamin B6-rich foods such as poultry, fish, and fortified cereals
Avoidance of excessive alcohol consumption to reduce malabsorption risk
Screening for malabsorption syndromes and treating underlying causes
Monitoring and managing chronic diseases that impair vitamin B6 metabolism
Education on recognizing early symptoms to prompt timely medical evaluation
Outcome & Complications
Complications
Irreversible peripheral neuropathy if deficiency is prolonged and untreated
Seizures refractory to standard anticonvulsants without pyridoxine supplementation
Neuropsychiatric disorders including depression and cognitive decline
Microcytic anemia due to impaired heme synthesis
Increased risk of cardiovascular disease from elevated homocysteine levels
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Vitamin B6 (Pyridoxine) Deficiency versus Vitamin B12 Deficiency
Vitamin B6 (Pyridoxine) Deficiency | Vitamin B12 Deficiency |
|---|---|
Normal methylmalonic acid with elevated homocysteine levels | Elevated methylmalonic acid and homocysteine levels |
Peripheral neuropathy without posterior column involvement | Subacute combined degeneration causing posterior column and corticospinal tract dysfunction |
Dietary deficiency or isoniazid use | History of pernicious anemia or malabsorption syndromes |
Vitamin B6 (Pyridoxine) Deficiency versus Copper Deficiency
Vitamin B6 (Pyridoxine) Deficiency | Copper Deficiency |
|---|---|
Predominantly peripheral neuropathy with irritability and seizures in severe cases | Myelopathy with sensory ataxia and spasticity similar to B12 deficiency |
Low plasma pyridoxal phosphate levels | Low serum copper and ceruloplasmin levels |
Poor dietary intake or certain medications like isoniazid | History of gastric surgery or excessive zinc intake |
Vitamin B6 (Pyridoxine) Deficiency versus Isoniazid Toxicity
Vitamin B6 (Pyridoxine) Deficiency | Isoniazid Toxicity |
|---|---|
No isoniazid exposure | Recent or ongoing treatment with isoniazid |
Improvement with pyridoxine supplementation but no drug exposure | Improvement with pyridoxine supplementation |
Low plasma pyridoxal phosphate levels | Normal B6 levels but functional deficiency due to drug interference |
Vitamin B6 (Pyridoxine) Deficiency versus Biotinidase Deficiency
Vitamin B6 (Pyridoxine) Deficiency | Biotinidase Deficiency |
|---|---|
More common in adults or older children | Presents in infancy or early childhood |
Low pyridoxal phosphate levels | Low biotinidase enzyme activity |
Peripheral neuropathy and irritability | Seizures, hypotonia, and developmental delay |
Vitamin B6 (Pyridoxine) Deficiency versus Folate Deficiency
Vitamin B6 (Pyridoxine) Deficiency | Folate Deficiency |
|---|---|
Normal folate with elevated homocysteine and normal methylmalonic acid | Low serum folate with elevated homocysteine but normal methylmalonic acid |
Neurologic symptoms with or without anemia | Megaloblastic anemia without neurologic symptoms |
Poor dietary intake or drug interference affecting B6 metabolism | Poor dietary intake or malabsorption |